TRANSPHORM INC (TGAN) Stock Analyst Earnings Estimates
NASDAQ:TGAN - Nasdaq - US89386L1008 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.37M -4.69% | 24.05M 111.52% | 16.51M -31.35% | 25.306M 53.28% | 40.866M 61.49% | 56.814M 39.03% | |
| EBITDA YoY % growth | -12.56M -17.38% | -9.06M 27.87% | -27.81M -206.95% | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.4M -12.42% | -9.9M 26.12% | -28.78M -190.71% | -20.128M 30.06% | -17.952M 10.81% | N/A | |
| Operating Margin | -117.85% | -41.16% | -174.32% | -79.54% | -43.93% | N/A | |
| EPS YoY % growth | N/A | -0.21 | -0.46 -119.05% | -0.35 24.61% | -0.27 22.06% | -0.34 -24.53% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 41.15% | -0.08 -2.00% | -0.08 36.25% | -0.07 39.73% | -0.05 33.33% | -0.09 -12.50% | -0.09 -20.00% | -0.08 -23.08% |
| Revenue Q2Q % growth | 7.89M 147.18% | 8.548M 45.30% | 9.634M 92.30% | 10.705M 129.23% | 11.98M 51.84% | 13.056M 52.74% | 13.872M 43.99% | 14.586M 36.25% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.743M 43.13% | -5.049M 25.53% | -4.641M 28.58% | -4.08M 54.27% | -3.366M 29.03% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.11 31.25% | -0.09 | -0.02 | -19.83% |
| Q2 2024 Q2Q % growth | -0.12 -33.33% | -0.10 | -0.02 | -17.65% |
| Q1 2024 Q2Q % growth | -0.08 | -0.11 | 0.03 | 30.28% |
| Q4 2023 Q2Q % growth | -0.13 -62.50% | -0.11 | -0.02 | -18.56% |
| Q3 2023 Q2Q % growth | -0.16 -77.78% | -0.10 | -0.06 | -56.86% |
| Q2 2023 Q2Q % growth | -0.09 -200.00% | -0.10 | 0.01 | 13.92% |
| Q1 2023 Q2Q % growth | -0.08 38.46% | -0.08 | 0.00 | -2.30% |
| Q4 2022 Q2Q % growth | -0.08 38.46% | -0.08 | 0.00 | -4.58% |
| Q3 2022 Q2Q % growth | -0.09 | -0.10 | 0.01 | 5.46% |
| Q2 2022 Q2Q % growth | 0.09 | 0.02 | 0.07 | 278.21% |
| Q1 2022 Q2Q % growth | -0.13 | -0.11 | -0.02 | -15.86% |
| Q4 2021 Q2Q % growth | -0.13 | -0.15 | 0.02 | 15.03% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 4.67M 4.01% | 6.29M | -1.62M | -25.76% |
| Q2 2024 Q2Q % growth | 5.01M 36.51% | 5.406M | -396K | -7.33% |
| Q1 2024 Q2Q % growth | 5.883M 14.01% | 6.044M | -161K | -2.66% |
| Q4 2023 Q2Q % growth | 3.192M -35.25% | 4.761M | -1.569M | -32.96% |
| Q3 2023 Q2Q % growth | 4.49M -2.39% | 4.488M | 2K | 0.04% |
| Q2 2023 Q2Q % growth | 3.67M -67.52% | 3.669M | 1K | 0.03% |
| Q1 2023 Q2Q % growth | 5.16M 60.25% | 5.352M | -192K | -3.59% |
| Q4 2022 Q2Q % growth | 4.93M 101.39% | 5.018M | -88K | -1.75% |
| Q3 2022 Q2Q % growth | 4.6M 128.86% | 4.08M | 520K | 12.75% |
| Q2 2022 Q2Q % growth | 11.3M 485.49% | 11.866M | -566K | -4.77% |
| Q1 2022 Q2Q % growth | 3.22M -49.13% | 2.55M | 670K | 26.27% |
| Q4 2021 Q2Q % growth | 122.55% | 2.448M | % | |
| Q3 2021 Q2Q % growth | 2.01M -79.74% | % | ||
| Q2 2021 Q2Q % growth | 1.93M 94.95% | % | ||
| Q1 2021 Q2Q % growth | 6.33M 1,191.84% | % | ||
| Q4 2020 Q2Q % growth | 1.1M 107.55% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 6.25% | 6.25% | 0% | 0% |
| Revenue | 8.08% | 8.08% | 2.63% | 2.63% |